PD-1 Antibody Expressing mesoCAR-T Cells for Mesothelin Positive Advanced Solid Tumor
Clinical trial NCT03615313 · UNKNOWN
Trial details
- NCT number
- NCT03615313
- Sponsor
- Shanghai Cell Therapy Research Institute
- Status
- UNKNOWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-08-06
- Primary completion
- 2020-08-03
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.